The pharmaceutical industry is likelier to use active cold chains to increase stability. Numerous medical products must remain in temperature-controlled climates — otherwise, they could lose efficacy.

The landscape of healthcare provider (HCP) engagement has undergone a fundamental transformation. While traditional ...

ICER's blasted pharma pricing for years, but now drugmakers are 'rolling up their sleeves' to cooperate With Dupixent for example ... evaluations—longevity, quality of life, adverse events ...

Stock market sell-offs are often great opportunities to buy dividend stocks. That's because dividend yields move in the ...

Kirsten Ostherr asks, 'What if we engaged with our health care narratives with the same fervor we bring to refreshing our ...

Spectris PLC, a British dividend aristocrat, shows signs of recovery with orders growing again, and efficiency actions ...

Regulatory and reimbursement pathways should consider indirect benefits in addition to direct health benefits when evaluating ...

M&A is an integral part of the lifecycle of pharma companies and a key strategy ... such as minutes of management review meetings and quality metrics which will enable them to quickly assess ...

Complaints about the high cost of private healthcare services in South Africa are nothing new. For the last two decades, ...

Q4 2024 Earnings Call Transcript March 17, 2025 Sangamo Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, expectations were $-0.09. Operator: Good afternoon, and welcome ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...